Misattribution bias of threat-related facial expressions is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder.

European Psychiatry : the Journal of the Association of European Psychiatrists
Preethi PremkumarVeena Kumari

Abstract

While it is known that patients with schizophrenia recognize facial emotions, specifically negative emotions, less accurately, little is known about how they misattribute these emotions to other emotions and whether such misattribution biases are associated with symptoms, course of the disorder, or certain cognitive functions. Outpatients with schizophrenia or schizoaffective disorder (n=73) and healthy controls (n=30) performed a computerised Facial Emotion Attribution Test and Wisconsin Card Sorting Test (WCST). Patients were also rated on the Positive and Negative Syndrome Scale (PANSS). Patients were poor at recognizing fearful and angry emotions and attributed fear to angry and angry to neutral expressions. Fear-as-anger misattributions were predicted independently by a longer duration of illness and WCST perseverative errors. The findings show a bias towards misattributing fearful and angry facial emotions. The propensity for fear-as-anger misattribution biases increases as the length of time that the disorder is experienced increases and a more rigid style of information processing is used. This, at least in part, may be perpetuated by subtle fearfulness expressed by others while interacting with people with schizophrenia.

References

Sep 1, 1991·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·D FrommM A Oakley
Jun 1, 1989·The British Journal of Medical Psychology·S Kaney, R P Bentall
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Mar 1, 1986·Archives of General Psychiatry·T E FeinbergE Walker
Aug 1, 1993·The Journal of Nervous and Mental Disease·J C BorodJ Welkowitz
Jan 1, 1996·European Archives of Psychiatry and Clinical Neuroscience·W WölwerW Gaebel
Jul 23, 1998·Neuropsychology·R W Heinrichs, K K Zakzanis
Aug 27, 1998·Schizophrenia Bulletin·M K MandalA B Prasad
Aug 28, 1998·Schizophrenia Research·J Addington, D Addington
Apr 11, 2001·Schizophrenia Research·J EdwardsR J Wales
Nov 13, 2001·Clinical Psychology Review·R P BentallP Kinderman
Dec 1, 2001·Schizophrenia Research·Rosemary ToomeyMichael F Green
Apr 5, 2002·Psychological Bulletin·Hillary Anger Elfenbein, Nalini Ambady
Nov 5, 2002·Schizophrenia Research·Mark J Sergi, Michael F Green
Sep 30, 2003·The American Journal of Psychiatry·Christian G KohlerRuben C Gur
Mar 3, 2004·The American Journal of Psychiatry·Leanne M WilliamsEvian Gordon
Apr 30, 2004·CNS Spectrums·Zeinab Abdi, Tonmoy Sharma
Aug 26, 2004·Journal of the International Neuropsychological Society : JINS·Vasilis P BozikasAthanasios Karavatos
Nov 25, 2004·Schizophrenia Research·Beatrice de GelderPaul Hodiamont
Dec 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Katarzyna Kucharska-PieturaMary L Phillips
Jan 27, 2006·Behaviour Research and Therapy·Suzanne JolleyDavid Hemsley
Mar 4, 2006·The American Journal of Psychiatry·Frank SchneiderUte Habel
Jul 4, 2006·Neuropsychologia·T A RussellM L Phillips
Aug 12, 2006·Journal of Psychiatric Research·Preethi PremkumarTonmoy Sharma
Mar 14, 2007·Cognitive Neuropsychiatry·Christian G Kohler, Elizabeth A Martin
Apr 3, 2007·Psychiatry Research·Leanne M WilliamsAnthony W F Harris

❮ Previous
Next ❯

Citations

Dec 3, 2013·Community Mental Health Journal·Hyuk ImHyo Young Lee
Mar 20, 2010·Journal of the International Neuropsychological Society : JINS·Laura A Brown, Alex S Cohen
Dec 31, 2009·European Journal of Public Health·Marie NorredamAllan Krasnik
Jul 3, 2013·European Journal of Public Health·Cendrine Bursztein LipsicasArmin Schmidtke
Jul 9, 2010·Nursing Ethics·Lora Humphrey Beebe, Kathlene Smith
Aug 24, 2013·Psychiatry·Chieh-Hsin LinHsien-Yuan Lane
Dec 3, 2014·Brain and Cognition·Ilona PapousekAndreas Fink
Mar 13, 2015·International Journal of Prisoner Health·Andrew ForresterPiyal Sen
Dec 1, 2009·Acta Neuropsychiatrica·Paola RoccaFilippo Bogetto
Apr 29, 2014·Issues in Mental Health Nursing·Lora BeebeChad Phillips
Feb 2, 2010·Archives of Psychiatric Nursing·Lora Humphrey Beebe, Kathlene Smith
Jan 24, 2012·Journal of Psychosocial Nursing and Mental Health Services·Lora H Beebe, Robin Faust Harris
Mar 31, 2010·Journal of Psychosocial Nursing and Mental Health Services·Lora Humphrey BeebeSheila White
Jan 3, 2013·International Journal of Mental Health Nursing·Lora Humphrey Beebe, Robin Faust Harris
Nov 16, 2010·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Tanja Maria MichelPeter Riederer
Feb 14, 2015·Psychological Medicine·J van der WaerdenUNKNOWN EDEN Mother–Child Cohort Study Group
Jun 7, 2015·Health Promotion International·Susanne Sundell LecerofPer-Olof Östergren
Feb 2, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jeffrey S BedwellYuri Rassovsky
Sep 10, 2014·Frontiers in Psychology·Thibaut DondaineBruno Millet
Sep 7, 2016·Journal of Behavior Therapy and Experimental Psychiatry·Tobias E HillmannTania M Lincoln
Mar 6, 2010·Clinical Schizophrenia & Related Psychoses·Lora Humphrey BeebeO Dessieux
Feb 9, 2017·Journal of the American Psychiatric Nurses Association·Karen Goyette Pounds
May 21, 2019·European Archives of Psychiatry and Clinical Neuroscience·Viola BulgariGiuseppe Carrà
Jun 2, 2020·European Child & Adolescent Psychiatry·Steven M GillespieAhmad M Abu-Akel
Mar 16, 2017·Nordic Journal of Psychiatry·Giuseppe DelvecchioPaolo Brambilla
Mar 24, 2021·Cognitive Neuropsychiatry·Nathan Caruana, Kiley Seymour

❮ Previous
Next ❯

Methods Mentioned

BETA
cognitive behavioural therapy

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.